Study summary

The objective of this study was to evaluate the efficacy and safety of enzalutamide treatment in patients with progressive metastatic castration-resistant prostate cancer previously treated with abiraterone acetate.

Additional Study Details

Phase
4
Product
  • Enzalutamide
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    215
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Scientific Results Summary 2
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate Enzalutamide after Abiraterone in Metastatic Castration-Resistant Prostate Cancer? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Site DE49013
      Reutlingen, Germany, 72764
      Completed
      Site FR33015
      Angers cedex 02, France, 49055
      Withdrawn
      Site ES34007
      Sevilla, Sevilla, Spain, 41013
      Completed
      Site DE49005
      Nuertingen, Baden-Wuerttemberg, Germany, 72622
      Completed
      Site DE49015
      Bergisch Gladbach, NW, Germany, 51427
      Completed
      Site GB44001
      Sutton, Surrey, United Kingdom, SM2 5PT
      Withdrawn
      Site BE32006
      Turnhout, Belgium, 2300
      Completed
      Site FR33003
      Marseille CEDEX 9, France, 13273
      Completed
      Site BE32004
      Gent, Belgium, 9000
      Completed
      Site FR33009
      Caen Cedex 05, France, 14076
      Completed
      Site GB44002
      Glasgow, United Kingdom, G12 0YN
      Completed
      Site DE49008
      Hamburg, Germany, 22399
      Withdrawn
      Site FR33006
      Lille, France, 59037
      Completed
      Site FR33014
      Le Mans, France, 72015
      Completed
      Site GB44010
      Plymouth, United Kingdom, PL6 8DH
      Completed
      Site DE49001
      Hamburg, Hamburg, Germany, 22081
      Completed
      Site DE49014
      Berlin, Germany, 10247
      Completed
      Site FR33011
      Paris, France, 75005
      Withdrawn
      Site DE49011
      Waldshut-Tiengen, Germany, 79761
      Completed
      Site FR33002
      Nimes, France, 30029
      Completed
      Site DE49007
      Hannover, Germany, 30625
      Completed
      Site ES34004
      Santiago de Compostela, A Coruna, Spain, 15706
      Completed
      Site ES34001
      Madrid, Madrid, Spain, 28007
      Completed
      Site ES34006
      Barcelona, Barcelona, Spain, 08025
      Completed
      Site FR33012
      Villejiuf, France, 94805
      Completed
      Site DE49016
      Duesseldorf, Germany, 40225
      Completed
      Site FR33001
      Paris cedex 15, France, 75908
      Completed
      Site ES34009
      Badalona, Spain, 8916
      Completed
      Site DE49003
      Berlin, Berlin, Germany, 12200
      Completed
      Site BE32002
      Liege, Belgium, 4000
      Completed
      Site ES34003
      Madrid, Madrid, Spain, 28034
      Completed
      Site ES34010
      Madrid, Madrid, Spain, 28044
      Completed
      Site GB44007
      London, United Kingdom, SE1 9RT
      Completed
      Site BE32007
      Hasselt, Belgium, 3500
      Completed
      Site BE32003
      Kortrijk, Belgium, 8500
      Completed
      Site DE49012
      Munster, Germany, 48149
      Completed
      Site FR33008
      Nantes Saint Herblain Cedex, France, 44805
      Completed
      Site FR33005
      Suresnes, France, 92151
      Completed
      Site DE49002
      Heidelberg, Germany, 69120
      Completed
      Site DE49010
      Dresden, Germany, 01307
      Withdrawn
      Site ES34005
      Pamplona, Navarra, Spain, 31008
      Completed
      Site DE49017
      Duisburg, NRW, Germany, 47179
      Completed
      Site DE49004
      Goettingen, Germany, 37075
      Completed
      Site GB44006
      Withington, United Kingdom, M204BX
      Completed
      Site GB44004
      Birmingham, United Kingdom, B15 2TT
      Completed
      Site GB44003
      Northwood, Middlesex, United Kingdom, HA6 2RN
      Completed
      Site FR33013
      Lyon Cedex 3, France, 69003
      Completed
      Site DE49006
      Tubingen, Germany, 72076
      Completed
      Site FR33007
      Rennes, France, 35042
      Completed
      Site FR33010
      Creteil cedex, France, 94010
      Completed
      Site ES34011
      Barcelona, Spain, 08003
      Completed
      Site GB44009
      Brighton, United Kingdom, BN2 5BE
      Completed
      Site ES34002
      Madrid, Madrid, Spain, 28040
      Completed
      Site BE32001
      Brussels, Flemish Brabant, Belgium, 1200
      Completed
      Site ES34008
      Barcelona, Barcelona, Spain, 08035
      Completed
      Site DE49009
      Bonn, Germany, 53111

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?